New horny layer marker proteins for evaluating skin condition in atopic dermatitis

International Archives of Allergy and Immunology

Volumn 150, Issue 1, 2009, Pages 89-101

  Yamane, Yumiko ^a   Moriyama, Kayano ^b   Yasuda, Chie ^b   Miyata, Satoshi ^c   Aihara, Michiko ^a   Ikezawa, Zenro ^a   Miyazaki, Kaoru ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Central Research Development Laboratory Fancl Corporation   (Japan)

Author keywords

Albumin; Atopic dermatitis; Biomarkers; Fatty acid binding protein 5; Horny layer

Indexed keywords

ALBUMIN; ALPHA ENOLASE; APOLIPOPROTEIN A1; BIOCHEMICAL MARKER; BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN 5; IMMUNOGLOBULIN E; LIPOCORTIN 2; PROTEIN; SQUAMOUS CELL CARCINOMA ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FOREARM; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATION; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; RASH; SKIN; STRATUM CORNEUM; WATER LOSS;

ADOLESCENT; ADULT; ALBUMINS; ANNEXIN A2; ANTIGENS, NEOPLASM; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; SERPINS; YOUNG ADULT;

EID: 63349097914     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210385     Document Type: Article

References (33)

1. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA: New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-657.
2. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q: Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991; 173: 775-778.
3. Hamid Q, Boguniewicz M, Leung DY: Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94: 870-876. (Pubitemid 24251022)
4. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY: In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996; 98: 225-231.
5. Grewe M, Bruijnzeel-Koomen CA, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J: A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19: 359-361. (Pubitemid 28392277)
6. Grewe M, Gyufko K, Schöpf E, Krutmann J: Lesional expression of interferon-gamma in atopic eczema. Lancet 1994; 343: 25-26. (Pubitemid 2008634)
7. Sator PG, Schmidt JB, Hönigsmann H: Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 2003; 48: 352-358.
8. Charman C, Williams H: Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000; 136: 763-769. (Pubitemid 30407434)
9. Mukai H, Noguchi T, Kamimura K, Nishioka K, Nishiyama S: Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis. J Dermatol 1990; 17: 477-481. (Pubitemid 20327409)
10. Hanifin J, Rajka G: Diagnostic features of atopic dermatitis. Acta Dermatol Venereol Suppl 1980; 92: 44-47.
11. Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A: Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997; 195: 10-19. (Pubitemid 27326702)
12. Leung DY: Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997; 107(suppl 1): 25-30. (Pubitemid 27019968)
13. Siegenthaler G, Hotz R, Chatellard-Gruaz D, Didierjean L, Hellman U, Saurat JH: Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro. Biochem J 1994; 302: 363-371. (Pubitemid 24280086)
14. O'Shaughnessy RF, Seery JP, Celis JE, Frischauf A, Watt FM: PA-FABP, a novel marker of human epidermal transit amplifying cells revealed by 2D protein gel electrophoresis and cDNA array hybridisation. FEBS Lett 2000; 486: 149-154.
15. Iizuka H, Ishida-Yamamoto A, Honda H: Epidermal remodelling in psoriasis. Br J Dermatol 1996; 135: 433-438.
16. Iizuka H, Honda H, Ishida-Yamamoto A: Epidermal remodeling in psoriasis (II): a quantitative analysis of the epidermal architecture. J Invest Dermatol 1997; 109: 806-810. (Pubitemid 28053533)
17. Kassam G, Choi KS, Ghuman J, Kang HM, Fitzpatrick SL, Zackson T, Zackson S, Toba M, Shinomiya A, Waisman DM: The role of annexin II tetramer in the activation of plasminogen. J Biol Chem 1998; 273: 4790-4799. (Pubitemid 28103230)
18. Pancholi V: Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 2001; 58: 902-920. (Pubitemid 32652817)
19. Gitlits VM, Toh BH, Sentry JW: Disease association, origin, and clinical relevance of autoantibodies to the glycolytic enzyme enolase. J Investig Med 2001; 49: 138-145.
20. Neuber K, Mähnss B, Hübner C, Gergely H, Weichenthal M: Autoantibodies against CD28 are associated with atopic diseases. Clin Exp Immunol 2006; 146: 262-269. (Pubitemid 44581341)
21. Ochs RL, Muro Y, Si Y, Ge H, Chan EK, Tan EM: Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 2000; 105: 1211-1220. (Pubitemid 30418802)
22. Takeda A, Yamamoto T, Nakamura Y, Takahashi T, Hibino T: Squamous cell carcinoma antigen is a potent inhibitor of cysteine proteinase cathepsin L. FEBS Lett 1995; 359: 78-80.
23. Schick C, Pemberton PA, Shi GP, Kamachi Y, Cataltepe S, Bartuski AJ, Gornstein ER, Brömme D, Chapman HA, Silverman GA: Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 1998; 37: 5258-5266.
24. Schick C, Kamachi Y, Bartuski AJ, Cataltepe S, Schechter NM, Pemberton PA, Silverman GA: Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J Biol Chem 1997; 272: 1849-1855. (Pubitemid 27045716)
25. Takeda A, Higuchi D, Takahashi T, Ogo M, Baciu P, Goetinck PF, Hibino T: Overexpression of serpin squamous cell carcinoma antigens in psoriatic skin. J Invest Dermatol 2002; 118: 147-154. (Pubitemid 34107436)
26. Mitsuishi K, Nakamura T, Sakata Y, Yuyama N, Arima K, Sugita Y, Suto H, Izuhara K, Ogawa H: The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis. Clin Exp Allergy 2005; 35: 1327-1333. (Pubitemid 43919826)
27. Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML: The objective severity assessment of atopic dermatitis score: an objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 2003; 139: 1417-1422. (Pubitemid 37433131)
28. Seidenari S, Giusti G: Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 1995; 75: 429-433. (Pubitemid 26051887)
29. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96: 523-526.
30. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, El Houate B, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446.
31. Nomura T, Sandilands A, Akiyama M, Liao H, Evans AT, Sakai K, Ota M, Sugiura H, Yamamoto K, Sato H, Palmer CN, Smith FJ, McLean WH, Shimizu H: Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 2007; 119: 434-440. (Pubitemid 46210082)
32. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, Liao H, Evans AT, Goudie DR, Lewis-Jones S, Arseculeratne G, Munro CS, Sergeant A, O'Regan G, Bale SJ, Compton JG, DiGiovanna JJ, Presland RB, Fleckman P, McLean WH: Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38: 337-342. (Pubitemid 43315757)
33. McGrath JA, Uitto J: The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med 2008; 14: 20-27.